Infectious Disease
RSSArticles
-
Public Reporting of Central-line Infections Called into Question
Central line-associated infections, particularly bloodstream infections (BSI), remain a huge issue in our technological age. -
Clinical Briefs in Primary Care supplement
-
Pharmacology Watch: Tiotropium for Uncontrolled Asthma
In this issue: Tiotropium for uncontrolled asthma, sibutramine pulled from market, incidence and mortality data from WHI, FDA Actions. -
Updates by Carol A. Kemper, MD, FACP
During the 2007-2008 and 2008-2009 influenza seasons, children ages 1-3 years, with influenza-like symptoms, were randomized to receive oseltamivir suspension vs. matching placebo for 5 days. -
Monkeypox Epidemiology in the Post Smallpox-vaccination Era: Major Increases in the Democratic Republic of Congo
Monkeypox is an orthopoxvirus related to variola, which causes a clinically similar (although less severe) illness to smallpox. -
Hospital Infection Control & Prevention December 2010 Issue in PDF
-
Needlestick risks remain, but safety goal fades away
Eliminating needlesticks was once an official federal goal. The Centers for Disease Control and Prevention promoted it as a "health care challenge." More modestly, Healthy People 2010 set a measurable goal of reducing needlesticks among hospital-based health care workers by 30%. -
Pharmacology Watch
FDA Advisory Committee recommends approval of dabigatran, safety of proton pump inhibitors, effectiveness of glucosamine and chondroitin, FDA Actions. -
Primary Care Reports - Full November 2010 Issue in PDF
-
Clinical Briefs in Primary Care Supplement